(Q36775366)

English

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer

scientific article published on 21 March 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

2

object named as

S Muenst

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

object named as

F Gao

5

0 references

author name string

S D Soysal

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

T Barbie

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

T Fleming

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

G Spizzo

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

D Oertli

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

C T Viehl

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

E C Obermann

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

W E Gillanders

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

21 March 2013

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

108

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1480-1487

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

EpCAM in carcinogenesis: the good, the bad or the ugly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Dual expression lentiviral vectors for concurrent RNA interference and rescue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Nuclear signalling by tumour-associated antigen EpCAM

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

EpCAM (CD326) finding its role in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Frequent EpCam protein expression in human carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Molecular portraits of human breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

29 September 2017

EpCAM expression is an indicator of recurrence in basal-like breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

27 June 2018

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

5 September 2018

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

5 September 2018

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3629430

5 September 2018

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23519058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/23519058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue

1 reference

https://pubmed.ncbi.nlm.nih.gov/23519058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23519058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23519058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ep-CAM overexpression in breast cancer as a predictor of survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/23519058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23519058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2013.80

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36775366&oldid=2199313858"